Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
International Stem Cell Corp
ISCO
Healthcare
Biotechnology
International Stem Cell Corporation is a clinical-stage biotechnology company that is focused on therapeutic and biomedical product development. The Company is primarily a research and development company, for the therapeutic market, which has focused on advancing potential clinical applications of human parthenogenetic stem cells (hpSCs) for the treatment of various diseases of the central...
nervous system and liver diseases. The Company's products are based on human cell culture and a type of pluripotent stem cells and hpSCs. The Company's subsidiaries include Lifeline Cell Technology, LLC (LCT), which develops, manufactures and commercializes primary human cell research products for the biomedical market; Lifeline Skin Care, Inc. (LSC), which develops, manufactures and markets a category of anti-aging skin care products for anti-aging market, and Cyto Therapeutics Pty. Ltd. (Cyto Therapeutics) performs research and development (R&D) for the therapeutic market.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (OTCQB:ISCO)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
Next
(0)
•••
MissionIR
X
View Profile
View Bullboard History
Post by
MissionIR
on Jul 28, 2016 6:05pm
International Stem Cell Corp. (ISCO) Announces Successful In
International Stem Cell Corp. (ISCO) Announces Successful Intracranial Cell Transplantation in Phase I Clinical Study of ISC-hpNSC Before the opening bell, International Stem Cell
...more
(0)
•••
MissionIR
X
View Profile
View Bullboard History
Post by
MissionIR
on Jul 28, 2016 11:49am
International Stem Cell Corp. (ISCO) Reduces Risk through It
International Stem Cell Corp. (ISCO) Reduces Risk through Its Commercial Operations Although cash burn for International Stem Cell Corp. (OTCQB: ISCO) currently stands at over $0.5 million
...more
(0)
•••
MissionIR
X
View Profile
View Bullboard History
Post by
MissionIR
on Jul 20, 2016 5:20pm
International Stem Cell Corporation (ISCO) Insiders Inspire
International Stem Cell Corporation (ISCO) Insiders Inspire Confidence with Share Purchases Recent Form 4 filings with the U.S. Securities and Exchange Commission indicate that the
...more
(0)
•••
MissionIR
X
View Profile
View Bullboard History
Post by
MissionIR
on Jul 15, 2016 3:06pm
International Stem Cell Corp. (ISCO) Using Extract from Stem
International Stem Cell Corp. (ISCO) Using Extract from Stem Cells to Produce Cosmetic Skin Care Line Stem cells have near-limitless abilities. They divide, reproduce, and build on each
...more
(0)
•••
MissionIR
X
View Profile
View Bullboard History
Post by
MissionIR
on Jul 08, 2016 3:31pm
International Stem Cell Corp. (ISCO) Looking to Transform Pa
International Stem Cell Corp. (ISCO) Looking to Transform Parkinson’s Disease Treatment with ISC-hpNSC™ Clinical Trial Last month, International Stem Cell Corp. (OTCQB: ISCO
...more
(0)
•••
MissionIR
X
View Profile
View Bullboard History
Post by
MissionIR
on Jun 30, 2016 4:18pm
International Stem Cell Corp. (ISCO) Avoiding Ethical Issues
International Stem Cell Corp. (ISCO) Avoiding Ethical Issues with Stem Cells Derived From Unfertilized Eggs Human pluripotent stem cells are a type of cell that is self-replicating. In
...more
(0)
•••
MissionIR
X
View Profile
View Bullboard History
Post by
MissionIR
on Jun 24, 2016 3:13pm
International Stem Cell Corp. (ISCO) Neural Stem Cell Therap
International Stem Cell Corp. (ISCO) Neural Stem Cell Therapy – Ethical, Effective, and Homegrown A news story out this week (https://dtn.fm/SW1v5) in the MIT Technology Review recounts the
...more
(0)
•••
MissionIR
X
View Profile
View Bullboard History
Post by
MissionIR
on Jun 14, 2016 4:34pm
International Stem Cell Corp. (ISCO) Protecting its Technolo
International Stem Cell Corp. (ISCO) Protecting its Technology Worldwide A patent is essentially a government license that gives certain rights to the patent holder, excluding others from
...more
(0)
•••
MissionIR
X
View Profile
View Bullboard History
Post by
MissionIR
on Jun 08, 2016 7:06pm
Buy One get One Free with International Stem Cell Corporatio
Buy One get One Free with International Stem Cell Corporation (ISCO) The recent initiation report on International Stem Cell Corporation (OTCQB: ISCO) by Edison Investment Research looks at
...more
(0)
•••
MissionIR
X
View Profile
View Bullboard History
Post by
MissionIR
on Jun 02, 2016 3:58pm
International Stem Cell Corp. (ISCO) Advancing Clinical Deve
International Stem Cell Corp. (ISCO) Advancing Clinical Development Program for Parkinson’s Disease International Stem Cell Corp. (OTCQB: ISCO) is a biotechnology company that works with
...more
(0)
•••
MissionIR
X
View Profile
View Bullboard History
Post by
MissionIR
on Jun 02, 2016 3:42pm
International Stem Cell Corp. (ISCO) Publishes Results from
International Stem Cell Corp. (ISCO) Publishes Results from Preclinical Study of ISC-hpNSC® for Treatment of Parkinson’s Disease Before the opening bell, International Stem Cell
...more
(0)
•••
MissionIR
X
View Profile
View Bullboard History
Post by
MissionIR
on May 26, 2016 5:08pm
Edison Issues Initiation on International Stem Cell Corp. (I
Edison Issues Initiation on International Stem Cell Corp. (ISCO), Focus on Parkinson’s Potential In a May 16, 2016, press release, Edison Investment Research announced initiation of
...more
(0)
•••
MissionIR
X
View Profile
View Bullboard History
Post by
MissionIR
on May 26, 2016 4:47pm
International Stem Cell Corp. (ISCO) Moves toward Commenceme
International Stem Cell Corp. (ISCO) Moves toward Commencement of Phase I Clinical Trial through Partnership with Cryoport Earlier this week, Cryoport, Inc. (NASDAQ: CYRX), the world
...more
(0)
•••
MissionIR
X
View Profile
View Bullboard History
Post by
MissionIR
on May 23, 2016 5:07pm
International Stem Cell Corp. (ISCO) Teams with Leading Cryo
International Stem Cell Corp. (ISCO) Teams with Leading Cryogenic Logistics Provider for Impending Clinical Trial Before the opening bell, Cryoport, Inc. (NASDAQ: CYRX), a premier
...more
(0)
•••
MissionIR
X
View Profile
View Bullboard History
Post by
MissionIR
on May 20, 2016 4:51pm
International Stem Cell Corp. (ISCO) Covered in Report by Ed
International Stem Cell Corp. (ISCO) Covered in Report by Edison Investment Research Earlier this week, Edison Investment Research, a leading independent investment intelligence firm
...more
Prev
1
2
3
4
5
6
7
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >